MACROGENICS INC — Director's Dealing 2025

Jan 13, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-01-02

Reporting Person: Smith Beth Ann (VP, Controller & Treasurer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7889	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$31.43	2025-12-18	Common Stock (3000)		Direct
Employee Stock Option (right to buy)	$20.53	2027-02-15	Common Stock (2100)		Direct
Employee Stock Option (right to buy)	$28.94	2028-03-02	Common Stock (4000)		Direct
Employee Stock Option (right to buy)	$21.88	2029-02-21	Common Stock (19850)		Direct
Employee Stock Option (right to buy)	$11.50	2030-02-20	Common Stock (4500)		Direct
Employee Stock Option (right to buy)	$19.18	2031-02-22	Common Stock (5000)		Direct
Employee Stock Option (right to buy)	$10.15	2032-02-22	Common Stock (6000)		Direct
Employee Stock Option (right to buy)	$2.44	2032-06-13	Common Stock (8000)		Direct
Employee Stock Option (right to buy)	$4.82	2033-02-15	Common Stock (15000)		Direct
Restricted Stock Unit	$0		Common Stock (2190)		Direct
Employee Stock Option (right to buy)	$18.30	2034-02-08	Common Stock (12250)		Direct
Restricted Stock Unit	$0		Common Stock (4750)		Direct

Footnotes

F1: This option was granted on 12/18/2015 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F2: This option was granted on 2/15/2017 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F3: This option was granted on 3/2/2018 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F4: This option was granted on 2/21/2019 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F5: This option was granted on 2/20/2020 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F6: This option was granted on 2/22/2021 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F7: This option was granted on 2/22/2022 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F8: This option was granted on 6/13/2022 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F9: This option was granted on 2/15/2023 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F10: The restricted stock units (RSUs) were granted on 2/15/2023 and vested as to 50% of the total shares one year after the date of grant and will vest 50% two years after the date of grant.

F11: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F12: This option was granted on 2/8/2024 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F13: The restricted stock units (RSUs) were granted on 2/8/2024 and will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.